These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5539034)

  • 1. Plasma calcitonin activity in a patient with thyroid medullary carcinoma and her children with osteopetrosis.
    Verdy M; Beaulieu R; Demers L
    J Clin Endocrinol Metab; 1971 Feb; 32(2):216-21. PubMed ID: 5539034
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcitonin in human serum. Detection by tissue culture bioassay in medullary carcinoma of the thyroid and other disorders.
    Raisz LG; Au WY; Simmons H; Mandelstam P
    Arch Intern Med; 1972 Jun; 129(6):889-93. PubMed ID: 5033285
    [No Abstract]   [Full Text] [Related]  

  • 3. Sporadic hypercalcitoninemia: clinical and therapeutic consequences.
    Scheuba C; Kaserer K; Moritz A; Drosten R; Vierhapper H; Bieglmayer C; Haas OA; Niederle B
    Endocr Relat Cancer; 2009 Mar; 16(1):243-53. PubMed ID: 18987170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medullary carcinoma of the thyroid before age 2 years.
    Stjernholm MR; Freudenbourg JC; Mooney HS; Kinney FJ; Deftos LJ
    J Clin Endocrinol Metab; 1980 Aug; 51(2):252-3. PubMed ID: 7400295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualization of lymph node dissection in RET (rearranged during transfection) carriers at risk for medullary thyroid cancer: value of pretherapeutic calcitonin levels.
    Machens A; Lorenz K; Dralle H
    Ann Surg; 2009 Aug; 250(2):305-10. PubMed ID: 19638924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.
    Frank-Raue K; Döhring J; Scheumann G; Rondot S; Lorenz A; Schulze E; Dralle H; Raue F; Leidig-Bruckner G
    Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):550-3. PubMed ID: 20013610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relations of calcitonin and gastrin in the Zollinger-Ellison syndrome and medullary carcinoma of the thyroid.
    Sizemore GW; Go VL; Kaplan EL; Sanzenbacher LJ; Holtermuller KH; Arnaud CD
    N Engl J Med; 1973 Mar; 288(13):641-4. PubMed ID: 4734496
    [No Abstract]   [Full Text] [Related]  

  • 8. Radioactive iodine treatment in medullary thyroid carcinoma.
    Faik Erdogan M; Gursoy A; Erdogan G; Kamel N
    Nucl Med Commun; 2006 Apr; 27(4):359-62. PubMed ID: 16531922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Calcitonin and its significance for the diagnosis of medullary carcinoma of the thyroid].
    Gautvik KM
    Tidsskr Nor Laegeforen; 1973 May; 93(15):1143-8. PubMed ID: 4584540
    [No Abstract]   [Full Text] [Related]  

  • 10. Radioiodine as an adjunct to the surgical treatment of medullary thyroid carcinoma.
    Deftos LJ; Stein MF
    J Clin Endocrinol Metab; 1980 May; 50(5):967-8. PubMed ID: 7372781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum calcitonin in medullary thyroid carcinoma. Radioimmunoassay technique and diagnostic value.
    Almqvist S; Telenius-Berg M; Wästhed B
    Acta Med Scand; 1974 Sep; 196(3):177-80. PubMed ID: 4472910
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma calcitonin in medullary thyroid carcinoma.
    Lancet; 1983 Feb; 1(8320):338-9. PubMed ID: 6130340
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunoassay of human calcitonin.
    Tashijan AH; Howland BG; Melvin KE; Hill CS
    N Engl J Med; 1970 Oct; 283(17):890-5. PubMed ID: 5458052
    [No Abstract]   [Full Text] [Related]  

  • 14. Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia.
    Chi DD; Moley JF
    Surg Oncol Clin N Am; 1998 Oct; 7(4):681-706. PubMed ID: 9735129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated basal calcitonin levels in a patient with a hurthle-cell carcinoma of the thyroid and neuroendocrine differentiation: report of a case.
    Munitiz V; Martinez-Barba E; Riquelme J; Rodriguez JM; Piñero A; Parrilla P
    Surg Today; 2005; 35(5):404-6. PubMed ID: 15864423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations?
    Niccoli-Sire P; Murat A; Rohmer V; Gibelin H; Chabrier G; Conte-Devolx B; Visset J; Ronceray J; Jaeck D; Henry JF; Proye C; Carnaille B; Kraimps JL;
    Surgery; 2003 Dec; 134(6):1029-36; discussion 1036-7. PubMed ID: 14668737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia.
    Borchhardt KA; Heinzl H; Gessl A; Hörl WH; Kaserer K; Sunder-Plassmann G
    Kidney Int; 2006 Dec; 70(11):2014-20. PubMed ID: 17051143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Calcitonin determination as a possibility for the evaluation of surgical result in medullary thyroid carcinoma (C-cell carcinoma)].
    Horn J; Pfarr B; Ziegler R
    Langenbecks Arch Chir; 1975; Suppl():231-4. PubMed ID: 1207235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Calcitonin as a tumor marker. I. Medullary carcinoma of the thyroid].
    Galán Galán F; Garrido Peralta M
    Rev Clin Esp; 1982 Apr; 165(1):5-9. PubMed ID: 7122936
    [No Abstract]   [Full Text] [Related]  

  • 20. [Medullary thyroid carcinoma--familial or sporadic disease?].
    Høie J; Jørgensen OG; Nesland JM; Møller P; Bjøro K
    Tidsskr Nor Laegeforen; 1994 Oct; 114(25):2951-4. PubMed ID: 7974404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.